ADAR1 levels and the extent of CTSS RNA editing are associated with changes in cathepsin S levels in patients with atherosclerotic vascular diseases, including subclinical atherosclerosis, coronary artery disease, aortic aneurysms, and advanced carotid atherosclerotic disease (13). Here, CTSS is linked to coronary artery disorder.